[Skip to Navigation]
February 1989

The Cutting Edge

Author Affiliations

Northwestern University Medical School, Chicago
Ann Arbor, Mich

Arch Otolaryngol Head Neck Surg. 1989;115(2):149. doi:10.1001/archotol.1989.01860260023008

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In an effort to improve palliation and, perhaps, even cure of patients with persistent or recurrent squamous cell carcinoma of the head and neck after irradiation and surgery or chemotherapy, researchers at Memorial Medical Center of Long Beach (Calif) have treated such patients with interstitial hyperthermia concomitant with interstitial irradiation (thermoendocurie therapy). A. A. Puthawala and coworkers reported their initial experience with this approach at the Second International Head and Neck Oncology Research Conference. Forty-four patients with a biopsy-proven diagnosis of recurrent and/or persistent squamous cell carcinoma of the head and neck received thermoendocurie therapy for salvage. All patients had previously either undergone a course of external irradiation to doses of 66 to 80 Gy as a definitive treatment, or had received preoperative or postoperative treatment to doses of 50 to 60 Gy. The majority of these patients had also received systemic chemotherapy.

The treatment modality consisted of two interstitial

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution